Poly Medicure Approves Audited Financial Results and Recommends Dividend for FY 2025-26

Poly Medicure Approves Audited Financial Results and Recommends Dividend for FY 2025-26​

Poly Medicure Limited announced that its Board of Directors, during a meeting held on May 25, 2026, approved the company's audited financial results. The Board also recommended a dividend of Rs. 3.5 per Equity Share for the Financial Year 2025-26, subject to shareholder approval.

The meeting covered the approval of audited financial results (Consolidated and Standalone) for the Fourth quarter and the entire financial year ended March 31, 2026.

Auditor Appointments​

The Board also approved the re-appointment of auditors for the Financial Year 2026-27. PricewaterhouseCoopers Services LLP was re-appointed as an Internal Auditor, and M/s Oswal Sunil & Co. Chartered Accountants were also re-appointed for the same role.

Financial Performance Highlights​

The company released comprehensive financial results for the quarter and year ended March 31, 2026, providing details across Standalone and Consolidated financial statements, including Profit and Loss, Balance Sheet, and Cash Flow Statements.

The Consolidated Balance Sheet, as of March 31, 2026, showed the following major components:

• Total Equity and Liabilities: 3594533 (Amount not specified, assumed currency units)
• Shareholders' Funds: 3140350
• Total Current Liabilities: 91730
• Total Current Assets: 737630053

The Consolidated Statement of Profit and Loss for the year ended March 31, 2026, reported a Profit after tax of 33,133.47, along with other comprehensive income.

Major Acquisitions and Investments​

The company provided detailed information regarding recent acquisitions and business combinations that contributed to the consolidated financial statements:

1. Pendracare Group Acquisition: During the year ended March 31, 2026, the Group acquired 0% economic rights in Pendracare Group (comprising Pendracare Holdings BV and Weling Medical BV). The initial accounting for this business combination used a provisional fair value measurement and resulted in a Goodwill recognized in the Consolidated Financial Statements of 1612757.
2. Medistream SA Acquisition: The Group acquired 100% economic rights in Medistream SA, Switzerland (comprising Citeffe group). The total acquisition cost was 25,125.15 (€ in lacs), and the resultant Goodwill was formed from the excess of the acquisition cost over the fair value of assets acquired.
3. NCLT Approval: The Board noted that the Hon'ble NCLT of Allahabad approved the resolution plan submitted by the company for Himalayan Mineral Water Private Limited (Target Company). The total amount approved under the resolution plan amounted to < 3,316.00 lacs.

Operational Details​

In addition to the financial reports, the company noted that 33,775 equity shares were allotted on the Employees Stock Option Scheme 2020, with an exercise price of € 100 per share.

The management confirmed that the financial results are prepared in accordance with the principles and procedures of India Accounting Standards (Indian Accounting Standards).

POLYMED Stock Price Movement​

Shares of Poly Medicure Limited today slipped by 4.89% to settle at ₹1547.2. The stock settled at this lower level amid a total traded volume of 167,446 shares.